May 13, 2020   SOURCE: PR NewsWire

Global Fibromyalgia Market, Pipeline, Epidemiology, Competitive Analysis, Drug Sales and Shares (2016-2024)

DUBLIN, May 13, 2020 /PRNewswire/ -- The "Global Fibromyalgia Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering.

https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

This research report provides comprehensive insights into the Fibromyalgia pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. The research analyzes and forecasts the Fibromyalgia market size and drug sales. It also provides insights into Fibromyalgia epidemiology and late stage pipeline.

Research Scope

    --  Countries: US, Germany, France, Italy, Spain, UK, Japan, Europe, Global
    --  Fibromyalgia pipeline: Find out drugs in clinical trials for the
        treatment of Fibromyalgia by development phase 3, phase 2, and phase 1,
        by pharmacological class and company
    --  Fibromyalgia epidemiology: Find out the number of patients diagnosed
        (prevalence) with Fibromyalgia by countries
    --  Fibromyalgia drugs: Identify key drugs marketed and prescribed for
        Fibromyalgia in the US, including trade name, molecule name, and company
    --  Fibromyalgia drugs sales: Find out the sales value for Fibromyalgia
        drugs by countries
    --  Fibromyalgia market valuations: Find out the market size for
        Fibromyalgia drugs in 2019 by countries. Find out how the market
        advanced from 2016 and forecast to 2024
    --  Fibromyalgia drugs market share: Find out the market shares for key
        drugs by countries

Benefits of this Research

    --  Evaluate commercial market opportunities for Fibromyalgia drugs
    --  Synthesize insights for business development & licensing
    --  Track market size, competitor drug sales, market shares in the
        Fibromyalgia market
    --  Develop in-depth knowledge of competition and markets
    --  Analyze Fibromyalgia drug sales data to update your brand planning
        trackers
    --  Develop tactics and strategies to take advantage of opportunities in the
        market
    --  Track Market Events and Trends and analyze key events in the
        Fibromyalgia market
    --  Develop forecast models, healthcare frameworks, or economic models
    --  Answer key business questions; supports decision making in R&D to long
        term marketing strategies

Key Topics Covered

1. Fibromyalgia Treatment Options

2. Fibromyalgia Pipeline Insights
2.1. Fibromyalgia Phase 3 Clinical Trials
2.2. Fibromyalgia Phase 2 Clinical Trials
2.3. Fibromyalgia Phase 1 Clinical Trials

3. Fibromyalgia Epidemiology Analysis by Countries

4. US Fibromyalgia Market Insights
4.1. Marketed Drugs for Fibromyalgia in US
4.2. US Fibromyalgia Market Size & Forecast
4.3. US Fibromyalgia Drugs Sales & Forecast
4.4. US Fibromyalgia Market Share Analysis

5. Germany Fibromyalgia Market Insights
5.1. Marketed Drugs for Fibromyalgia in Germany
5.2. Germany Fibromyalgia Market Size & Forecast
5.3. Germany Fibromyalgia Drugs Sales Forecast
5.4. Germany Fibromyalgia Market Share Analysis

6. France Fibromyalgia Market Insights
6.1. Marketed Drugs for Fibromyalgia in France
6.2. France Fibromyalgia Market Size & Forecast
6.3. France Fibromyalgia Product Sales Forecast
6.4. France Fibromyalgia Market Share Analysis

7. Italy Fibromyalgia Market Insights
7.1. Marketed Drugs for Fibromyalgia in Italy
7.2. Italy Fibromyalgia Market Size & Forecast
7.3. Italy Fibromyalgia Product Sales Forecast
7.4. Italy Fibromyalgia Market Share Analysis

8. Spain Fibromyalgia Market Insights
8.1. Marketed Drugs for Fibromyalgia in Spain
8.2. Spain Fibromyalgia Market Size & Forecast
8.3. Spain Fibromyalgia Product Sales Forecast
8.4. Spain Fibromyalgia Market Share Analysis

9. UK Fibromyalgia Market Insights
9.1. Marketed Drugs for Fibromyalgia in UK
9.2. UK Fibromyalgia Market Size & Forecast
9.3. UK Fibromyalgia Product Sales Forecast
9.4. UK Fibromyalgia Market Share Analysis

10. Europe Fibromyalgia Market Insights
10.1. Europe Fibromyalgia Market Size & Forecast
10.2. Europe Fibromyalgia Product Sales Forecast
10.3. Europe Fibromyalgia Market Share Analysis

11. Japan Fibromyalgia Market Insights
11.1. Marketed Drugs for Fibromyalgia in Japan
11.2. Japan Fibromyalgia Market Size & Forecast
11.3. Japan Fibromyalgia Product Sales Forecast
11.4. Japan Fibromyalgia Market Share Analysis

12. Global Fibromyalgia Market Insights
12.1. Global Fibromyalgia Market Size & Forecast
12.2. Global Fibromyalgia Product Sales Forecast
12.3. Global Fibromyalgia Market Share Analysis

For more information about this report visit https://www.researchandmarkets.com/r/x1mj7x

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-fibromyalgia-market-pipeline-epidemiology-competitive-analysis-drug-sales-and-shares-2016-2024-301057833.html

SOURCE Research and Markets